Opicapone Analysis of Health Economic Costs in Clinical Practice in Parkinson's Disease UK Patients with Motor Fluctuations: Findings from the OPTIPARK Study

被引：0

|

作者：

Lees, A.

Reichmann, H.

Magalhaes, D.

Rocha, J.

Soares-da-Silva, P.

机构：

来源：

MOVEMENT DISORDERS | 2021年 / 36卷

关键词：

LEVODOPA; ADJUNCT;

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

505

引用

收藏

页码：S218 / S219

页数：2

相关论文

共 50 条

[1] Opicapone in Clinical Practice in Parkinson's Disease UK Patients with Motor Fluctuations: Findings from the OPTIPARK Study
Lees, A.
Reichmann, H.
Magalhaes, D.
Rocha, J.
Soares-da-Silva, P.
MOVEMENT DISORDERS, 2021, 36 : S219 - S219
[2] Opicapone in Clinical Practice in Parkinson's disease Patients with Motor Fluctuations: Findings from the OPTIPARK Study
Reichmann, H.
Lees, A.
Rocha, J. -F.
Magalhaes, D.
Soares-Da-Silva, P.
EUROPEAN JOURNAL OF NEUROLOGY, 2020, 27 : 322 - 323
[3] Opicapone in Clinical Practice in Parkinson's Disease Patients with Motor Fluctuations: Findings from the OPTIPARK Study
Reichmann, H.
Lees, A.
Rocha, J. -F.
Magalhaes, D.
Soares-da-Silva, P.
MOVEMENT DISORDERS, 2020, 35 : S475 - S475
[4] Opicapone in Parkinson's Disease German Patients with Motor Fluctuations: Findings from the OPTIPARK Study
Reichmann, H.
Lees, A.
Magalhaes, D.
Rocha, J.
Soares-da-Silva, P.
MOVEMENT DISORDERS, 2021, 36 : S232 - S233
[5] Opicapone in Parkinson's German Patients with Motor Fluctuations: findings from the OPTIPARK Study
Reichmann, H.
Lees, A.
Magalhaes, D.
Rocha, J.
Soares-da-Silva, P.
EUROPEAN JOURNAL OF NEUROLOGY, 2021, 28 : 354 - 355
[6] Opicapone Use in Clinical Practice across Germany: A Sub-Analysis of the OPTIPARK Study in Parkinson's Disease Patients with Motor Fluctuations
Reichmann, Heinz
Eggert, Karla
Oehlwein, Christian
Warnecke, Tobias
Lees, Andrew J.
Kemmer, Michael
Soares-da-Silva, Patricio
EUROPEAN NEUROLOGY, 2022, 85 (05) : 389 - 397
[7] Influence of onset of motor fluctuations on the effectiveness of opicapone in Parkinson's disease patients with motor fluctuations: findings from the real-world OPTIPARK study
Jost, W.
Reichmann, H.
Lees, A.
Marinho, D.
Magalhaes, D.
Rocha, J.
Soares-da-Silva, P.
MOVEMENT DISORDERS, 2021, 36 : S214 - S215
[8] Influence of demographic characteristics on the effectiveness of opicapone in Parkinson's disease patients with motor fluctuations: findings from the real-world OPTIPARK study
Mohamed, B.
Lees, A.
Reichmann, H.
Martins, D.
Magalhaes, D.
Rocha, J.
Soares-da-Silva, P.
MOVEMENT DISORDERS, 2021, 36 : S223 - S223
[9] Opicapone in Parkinson's patients with motor fluctuations and complications of therapy at baseline: the OPTIPARK study
Reichmann, H.
Lees, A.
Fonseca, M.
Magalhaes, D.
Rocha, J.
Soares-da-Silva, P.
EUROPEAN JOURNAL OF NEUROLOGY, 2021, 28 : 353 - 354
[10] Effectiveness of opicapone in Parkinson's disease patients with motor fluctuations according to baseline use of safinamide: findings from the real-world OPTIPARK study
Pavese, N.
Lees, A.
Reichmann, H.
Martins, D.
Magalhaes, D.
Rocha, J.
Soares-da-Silva, P.
MOVEMENT DISORDERS, 2021, 36 : S228 - S229

← 1 2 3 4 5 →